Liver transplantation for glycogen storage disease type Ia

Journal of Hepatology

Volumn 51, Issue 3, 2009, Pages 483-490

  Reddy, Srinevas K ^a   Austin, Stephanie L ^a   Spencer Manzon, Michele ^a   Koeberl, Dwight D ^a   Clary, Bryan M ^a   Desai, Dev M ^a   Smith, Alastair D ^a   Kishnani, Priya S ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Glycogen storage disease Ia; Hepatocellular adenoma; Hepatocellular carcinoma; Liver transplantation

Indexed keywords

CHOLESTEROL; GLUCOSE; LACTIC ACID; STARCH; TRIACYLGLYCEROL;

ADULT; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CYTOMEGALOVIRUS INFECTION; GLUCOSE BLOOD LEVEL; GLYCOGEN STORAGE DISEASE TYPE 1; GLYCOGEN STORAGE DISEASE TYPE 1A; HEMOGLOBIN BLOOD LEVEL; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY FUNCTION; LACTATE BLOOD LEVEL; LIVER ADENOMA; LIVER CELL CARCINOMA; LIVER GRAFT REJECTION; LIVER HEMORRHAGE; LIVER NECROSIS; LIVER TRANSPLANTATION; METABOLIC REGULATION; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; BLOOD GLUCOSE; CARCINOMA, HEPATOCELLULAR; CHOLESTEROL; FOLLOW-UP STUDIES; GLYCOGEN STORAGE DISEASE TYPE I; HUMANS; KIDNEY; LACTIC ACID; LIVER; LIVER NEOPLASMS; LIVER TRANSPLANTATION; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; TRIGLYCERIDES;

EID: 68049116914     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2009.05.026     Document Type: Article

References (40)

1. Chen Y.T. Glycogen storage disease. In: Scriver C.R., Beaudet A.L., Sly W.S., and Valle D. (Eds). The metabolic and molecular bases of inherited disease. 3rd ed. vol. 1 (2001), McGraw-Hill, New York 1521-1552
2. Rake J.P., Visser G., Labrune P., Leonard J.V., Ullrich K., and Smit G.P. Glycogen storage disease type I: diagnosis, management, clinical course, and outcome. Results of the European study on glycogen storage disease type I (ESGSD I). Eur J Pediatr 161 (2002) S20-S34
3. Smit G.P.A. The long-term outcome of patients with glycogen storage disease type Ia. Eur J Pediatr 152 Suppl. 1 (1993) S52-S55
4. Talente G.M., Coleman R.A., Alter C., Baker L., Brown B.I., Cannon R.A., et al. Glycogen storage disease in adults. Ann Intern Med 120 (1994) 218-226
5. Bianchi L. Glycogen storage disease I and hepatocellular tumors. Eur J Pediatr 152 (1993) S63-S70
6. Franco L.M., Krishnamurthy V., Bali D., Weinstein D.A., Arn P., Clary B., et al. Hepatocellular carcinoma in glycogen storage disease type Ia: a case series. J Inherit Metab Dis 288 (2005) 153-162
7. Lerut J.P., Ciccarelli O., Sempoux C., Danse E., deFlandre J., Horsmans Y., et al. Glycogenosis storage type I diseases and evolutive adenomatosis: an indication for liver transplantation. Transpl Int 16 (2003) 879-884
8. Weinstein D.A., and Wolfsdorf J.I. Effect of continuous glucose therapy with uncooked cornstarch on the long-term clinical course of type Ia glycogen storage disease. Eur J Pediatr 161 (2002) S35-S39
9. Coire C.I., Qizilbash A.H., and Castelli M.F. Hepatic adenomata in type Ia glycogen storage disease. Arch Pathol Lab Med 111 (1987) 166-169
10. Koeberl D.D., Kishnani P.S., and Chen Y.T. Glycogen storage disease types I and III: treatment updates. J Inherit Metab Dis 30 (2007) 159-164
11. Faivre L., Houssin D., Valayer J., Brouard J., Hadchouel M., and Bernard O. Long-term outcome of liver transplantation in patients with glycogen storage disease type Ia. J Inherit Metab Dis 22 (1999) 723-732
12. Lee P.J. Glycogen storage disease type I: pathophysiology of liver adenomas. Eur J Pediatr 161 (2002) S46-S49
13. Daublin G., Schwahn B., and Wendel U. Type I glycogen storage disease: favourable outcome on a strict management regimen avoiding increased lactate production during childhood and adolescence. Eur J Pediatr 161 (2002) S40-S45
14. Matern D., Starzl T.E., Arnaout W., Barnard J., Bynon J.S., Dhawan A., et al. Liver transplantation for glycogen storage disease types I, III, and IV. Eur J Pediatr 158 (1999) S43-S48
15. Liu P.P., de Villa V.H., Chen Y.S., Wang C.C., Wang S.H., Chiang Y.C., et al. Outcome of living done liver transplantation for glycogen storage disease. Transplant Proc 35 (2003) 366-368
16. Labrune P., Trioche P., Duvaltier I., Chevalier P., and Odievre M. Hepatocellular adenomas I glycogen storage disease type I and III: a series of 43 patients and review of the literature. J Pediatr Gastroenterol Nutr 24 (1997) 276-279
17. Rocco M.D., Calevo M.G., Taro M., Melis D., Allegri A.E., and Parenti G. Hepatocellular adenoma and metabolic balance in patients with type Ia glycogen storage disease. Mol Gen Metabol 93 (2008) 398-402
18. Labrune P. Glycogen storage disease type I: indications for liver and/or kidney transplantation. Eur J Pediatr 161 (2002) S53-S55
19. Wiesner R.H., McDiarmid S.V., Kamath P.S., Kremers W., Therneau T.M., Kosberg C.L., et al. MELD and PELD: application of survival models to liver allocation. Liver Transpl 7 (2001) 567-580
20. Botta F., Giannini E., Romagnoli P., Fasoli A., Malfatti F., Chiarbonello B., et al. MELD scoring system is useful for predicting prognosis in patients with liver cirrhosis and is correlated with residual liver function: a European study. Gut 52 (2003) 134-139
21. Wiesner R., Edwards E., Freeman R., Harper A., Kim R., Kamath P., et al. Model for end stage liver disease (MELD) and allocation of donor livers. Gastroenterology 124 (2003) 91-96
22. Reddy S.K., Kishnani P.S., Sullivan J.A., Koeberl D.D., Desai D.M., Skinner M.A., et al. Resection of hepatocellular adenoma in patients with glycogen storage disease type Ia. J Hepatol 47 (2007) 658-663
23. Kamath P.S., Wiesner R.H., Malinchoc M., Kremers W., Therneau T.M., Kosberg C.L., et al. A model to predict survival in patients with end-stage liver disease. Hepatology 33 (2001) 464-470
24. Rodriguez-Luna H., Vargas H.E., Moss A., Reddy K.S., Freeman R.B., and Mulligan D. Regional variations in peer reviewed liver allocation under the MELD system. Am J Transplant 5 (2005) 2244-2247
25. Davis M.K., and Weinstein D.A. Liver transplantation in children with glycogen storage disease: controversies and evaluation of the risk/benefit of this procedure. Pediatr Transplant 12 (2008) 137-145
26. Rake J.P., Visser G., Labrune P., Leonard J.V., Ullrich K., Smit G.P., et al. Guidelines for management of glycogen storage disease type I-European study on glycogen storage disease type I (ESGSD I). Eur J Pediatr 161 (2002) S112-S119
27. Mazzaferro V., Regalia E., Doci R., Andreola S., Pulvirenti A., Bozzetti F., et al. Liver transplantation for the treatment of small hepatocellular carcinoma in patients with cirrhosis. N Engl J Med 334 (1996) 693-700
28. Weinstein D.A., Roy C.N., Fleming M.D., Loda M.F., Wolfsdorf J.I., and Andrews N.C. Inappropriate expression of hepcidin is associated with iron refractory anemia: implications for anemia of chronic disease. Blood 100 (2002) 3776-3881
29. Roy C.N., Weinstein D.A., and Andrews N.C. The molecular biology of the anemia of chronic disease: a hypothesis. Pediatr Res 53 (2003) 507-512
30. Nicolas G., Bennoun M., Devaux I., Beaumont C., Grandchamp B., Kahn A., et al. Lack of hepcidin gene expression and severe tissue iron overload in upstream stimulatory factor 2 (USF2) knockout mice. Proc Natl Acad Sci USA 98 (2001) 8780-8785
31. Melis D., Parenti G., Gatti R., Casa R.D., Parini R., Riva E., et al. Efficacy of ACE-inhibitor therapy on renal disease in glycogen storage disease type I: a multicentre retrospective study. Clin Endocrinol 63 (2005) 19-25
32. Yiu W.H., Pan C.J., Ruef R.A., Peng W.T., Starost M.F., Mansfield B.C., et al. Angiotensin mediates renal fibrosis in the nephropathy of glycogen storage disease type Ia. Kidney Int 73 (2008) 716-723
33. Reitsma-Bierens W.C.C. Renal complications in glycogen storage disease type I. Eur J Pediatr 152 (1993) S60-S62
34. Baker L., Dahlem S., Goldfarb S., Kern E.F., Stanley C.A., Egler J., et al. Hyperfiltration and renal disease in glycogen storage disease, type I. Kidney Int 35 (1989) 1345-1350
35. Chen Y.T., Coleman R.A., Scheinman J.I., Kolbeck J.C., and Sidbury J.B. Renal disease in type I glycogen storage disease. NEJM 318 (1988) 7-11
36. Panaro F., Andorno E., Basile G., Morelli N., Bottino G., Fontana I., et al. Simultaneous liver-kidney transplantation for glycogen storage disease type Ia (von Gierke's disease). Transplant Proc 36 (2004) 1483-1484
37. Lee P.J., Muiesan P., and Heaton N. Successful pregnancy after combined renal-hepatic transplantation in glycogen storage disease type Ia. J Inherit Metab Dis 27 (2004) 537-538
38. Belingheri M., Ghio L., Saia A., Menni F., Trespidi L., Ferraresso M., et al. Combined liver-kidney transplantation in glycogen storage disease Ia: a case beyond the guidelines. Liver Transpl 13 (2007) 762-764
39. Desai M., and Neuberger N. Chronic liver allograft dysfunction. Transplant Proc 41 (2009) 773-776
40. Iyer S.G., Chen C.L., Wang C.C., Wang S.H., Concejero A.M., Liu Y.W., et al. Long-term results of living donor liver transplantation for glycogen storage disorders in children. Liver Transpl 13 (2007) 848-852